Navigation Links
Young researcher on the trail of herbal snakebite antidote
Date:9/17/2012

A PhD student at the University of Copenhagen has drawn on nature's own pharmacy to help improve the treatment of snakebites in Africa.

Marianne Molander from the University of Copenhagen's Faculty of Health and Medical Sciences has been working within a Danish team that has examined various plants native to the African continent in a bid to find locally available herbal antidotes.

"Snake venom antidotes are expensive, it's often a long way to the nearest doctor and it can be difficult to store the medicine properly in the warm climate. As a result many local people rely on natural resources for treating potentially fatal bites," says pharmacist and PhD student Marianne Molander.

The Danish researchers are now investigating African plants that have proven effective in treating snakebite. Armed with the results of their research they are set to provide guidance in the use of plants in remote areas where local people have limited access to Western medicine:

"We have particularly focused on the snake species Bitis arietans, which is widespread south of the Sahara. All snake venoms consist of a unique cocktail of enzymes, which results in rapid tissue death. Along with our African partners, we are currently testing plants that act as venom antidotes in remote regions of Africa. A hundred plants from Mali, 27 from South Africa and 13 from the Democratic Republic of Congo are now under the microscope," says Marianne Molander, PhD student in drug design and pharmacology at the University of Copenhagen.

Snake venom as medicine

100,000 people worldwide die each year from snakebites. Three times as many suffer permanent injuries, disability or amputations as a result of a bite to an arm or leg. The problem is greatest in tropical developing countries, where agricultural workers, women and children are the most likely victims. Although a million people in Africa are bitten by snakes each year - only half receive treatment.

But snake venom is not all bad. There are many instances where venom can be developed into drugs used, for example, in the treatment of hypertension, heart failure and diabetic kidney disease. The drug Aggrastat, which is used for chest pain, was developed using a peptide from an African viper.

Herbal healing in Africa

Historically plants have always been a major source of drugs. A quarter of all new medicinal products registered worldwide, come from plants or other natural resources. This impressive potential has its origins in the fact that plants have evolved to contain substances that prevent them being eaten or attacked by diseases. These biologically active defence compounds can sometimes be useful for developing new drugs. And Africa's poor use nature as their medicine cabinet.

"In Africa where much of the population can't afford medicine, there is a tradition of seeking out healers and alternative therapists, before turning to conventional medicine. Eighty percent visit the healer before they go to the hospital. Traditional herbal medicine is based on centuries of traditions and achievement, so the local shamans and medicine men are often a good place to start when you are looking for active substances with real pharmaceutical effects," says Marianne Molander.


'/>"/>

Contact: Marianne Molander
mmo@sund.ku.dk
(45) 61-18-56-33
University of Copenhagen
Source:Eurekalert

Related medicine news :

1. How is grief unique to young adults with cancer?
2. Younger Kids Likelier to Gain Weight After Tonsillectomy
3. Young Children Treated for Cancer May Be at Risk for PTSD: Study
4. Earlier treatment for young patients with chronic hepatitis B more effective in clearing virus
5. Almost 1 in 5 young children with cancer suffers from a trauma disorder
6. Magazines jeopardize and empower young womens sexuality
7. Parents and readers beware of stereotypes in young adult literature
8. Close contact with young people at risk of suicide has no effect
9. ADHD May Raise Girls Risk for Suicide as Young Adults
10. For young adults, appearance matters more than health, MU research suggests
11. Study links persistent and loud snoring in young children with problem behaviors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... New York (PRWEB) , ... ... ... Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light logistics ... it has entered into a definitive agreement to purchase Unitrans International Corporation, ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces ... active, healthy lifestyles and highlighting the importance of proactive eye and ear health. ... shares the latest innovations in hearing aid technology. , In this issue, ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... and financial consultations to communities throughout the greater DC region, is inaugurating a ... goal of rescuing local animals and training them to be companions for veterans ...
(Date:8/18/2017)... ... August 18, 2017 , ... MLM ... that serves communities throughout southern Florida, is working to support the Take Stock ... children from low income families. , The Take Stock In Children Foundation (TSC) ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: